Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study
- PMID: 33785495
- PMCID: PMC8727683
- DOI: 10.1136/bmjopen-2020-048391
Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study
Abstract
Objective: To assess medium-term organ impairment in symptomatic individuals following recovery from acute SARS-CoV-2 infection.
Design: Baseline findings from a prospective, observational cohort study.
Setting: Community-based individuals from two UK centres between 1 April and 14 September 2020.
Participants: Individuals ≥18 years with persistent symptoms following recovery from acute SARS-CoV-2 infection and age-matched healthy controls.
Intervention: Assessment of symptoms by standardised questionnaires (EQ-5D-5L, Dyspnoea-12) and organ-specific metrics by biochemical assessment and quantitative MRI.
Main outcome measures: Severe post-COVID-19 syndrome defined as ongoing respiratory symptoms and/or moderate functional impairment in activities of daily living; single-organ and multiorgan impairment (heart, lungs, kidneys, liver, pancreas, spleen) by consensus definitions at baseline investigation.
Results: 201 individuals (mean age 45, range 21-71 years, 71% female, 88% white, 32% healthcare workers) completed the baseline assessment (median of 141 days following SARS-CoV-2 infection, IQR 110-162). The study population was at low risk of COVID-19 mortality (obesity 20%, hypertension 7%, type 2 diabetes 2%, heart disease 5%), with only 19% hospitalised with COVID-19. 42% of individuals had 10 or more symptoms and 60% had severe post-COVID-19 syndrome. Fatigue (98%), muscle aches (87%), breathlessness (88%) and headaches (83%) were most frequently reported. Mild organ impairment was present in the heart (26%), lungs (11%), kidneys (4%), liver (28%), pancreas (40%) and spleen (4%), with single-organ and multiorgan impairment in 70% and 29%, respectively. Hospitalisation was associated with older age (p=0.001), non-white ethnicity (p=0.016), increased liver volume (p<0.0001), pancreatic inflammation (p<0.01), and fat accumulation in the liver (p<0.05) and pancreas (p<0.01). Severe post-COVID-19 syndrome was associated with radiological evidence of cardiac damage (myocarditis) (p<0.05).
Conclusions: In individuals at low risk of COVID-19 mortality with ongoing symptoms, 70% have impairment in one or more organs 4 months after initial COVID-19 symptoms, with implications for healthcare and public health, which have assumed low risk in young people with no comorbidities.
Trial registration number: NCT04369807; Pre-results.
Keywords: COVID-19; epidemiology; health policy; public health.
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.
Conflict of interest statement
Competing interests: AD, RB and MB are employees of Perspectum.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/8727683/bin/bmjopen-2020-048391f01.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/8727683/bin/bmjopen-2020-048391f02.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/8727683/bin/bmjopen-2020-048391f03.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/8727683/bin/bmjopen-2020-048391f04.gif)
![Figure 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/8727683/bin/bmjopen-2020-048391f05.gif)
Similar articles
-
Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study.Lancet Respir Med. 2023 Nov;11(11):1003-1019. doi: 10.1016/S2213-2600(23)00262-X. Epub 2023 Sep 22. Lancet Respir Med. 2023. PMID: 37748493 Free PMC article.
-
Multi-organ impairment and long COVID: a 1-year prospective, longitudinal cohort study.J R Soc Med. 2023 Mar;116(3):97-112. doi: 10.1177/01410768231154703. Epub 2023 Feb 14. J R Soc Med. 2023. PMID: 36787802 Free PMC article.
-
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5. Trials. 2021. PMID: 33430924 Free PMC article.
-
Post-COVID-19 syndrome: epidemiology, diagnostic criteria and pathogenic mechanisms involved.Rev Neurol. 2021 Jun 1;72(11):384-396. doi: 10.33588/rn.7211.2021230. Rev Neurol. 2021. PMID: 34042167 Review. English, Spanish.
-
Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis.Brain Behav Immun. 2022 Mar;101:93-135. doi: 10.1016/j.bbi.2021.12.020. Epub 2021 Dec 29. Brain Behav Immun. 2022. PMID: 34973396 Free PMC article. Review.
Cited by
-
Long COVID-19 Enigma: Unmasking the Role of Distinctive Personality Profiles as Risk Factors.J Clin Med. 2024 May 14;13(10):2886. doi: 10.3390/jcm13102886. J Clin Med. 2024. PMID: 38792428 Free PMC article.
-
Long COVID in Children, Adults, and Vulnerable Populations: A Comprehensive Overview for an Integrated Approach.Diseases. 2024 May 6;12(5):95. doi: 10.3390/diseases12050095. Diseases. 2024. PMID: 38785750 Free PMC article. Review.
-
Cohort profile: EFTER-COVID - a Danish nationwide cohort for assessing the long-term health effects of the COVID-19 pandemic.BMJ Open. 2024 May 6;14(5):e087799. doi: 10.1136/bmjopen-2024-087799. BMJ Open. 2024. PMID: 38719312 Free PMC article.
-
Prevalence and health effects of post-COVID-19 condition in Africa: a scoping review protocol.BMJ Open. 2024 May 2;14(5):e082519. doi: 10.1136/bmjopen-2023-082519. BMJ Open. 2024. PMID: 38697758 Free PMC article. Review.
-
High uptake of COVID-19 vaccines among healthcare workers in urban Uganda.PLoS One. 2024 Apr 16;19(4):e0277072. doi: 10.1371/journal.pone.0277072. eCollection 2024. PLoS One. 2024. PMID: 38626070 Free PMC article.
References
-
- World Health Organization . Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. interim guidance 13 March 2020, 2020. Available: https://apps.who.int/iris/handle/10665/331446
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous